Abbott Laboratories (ABT)

111.48
+0.99(+0.90%)
After Hours
111.50
+0.02(+0.02%)
- Real-time Data
  • Volume:
    2,803,936
  • Day's Range:
    110.43 - 111.53
  • 52 wk Range:
    101.24 - 142.60

ABT Overview

Prev. Close
110.49
Day's Range
110.43-111.53
Revenue
44.51B
Open
110.86
52 wk Range
101.24-142.6
EPS
4.83
Volume
2,803,936
Market Cap
195.23B
Dividend (Yield)
1.88
(1.69%)
Average Volume (3m)
4,920,956
P/E Ratio
22.53
Beta
0.699
1-Year Change
-9.41%
Shares Outstanding
1,751,219,743
Next Earnings Date
Oct 19, 2022
What is your sentiment on Abbott Labs?
or
Market is currently closed. Voting is open during market hours.

Abbott Laboratories Analysis

Abbott Laboratories Company Profile

Abbott Laboratories Company Profile

Abbott Laboratories is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its Established Pharmaceutical Products segment includes gastroenterology products, women’s health products, cardiovascular and metabolic products, pain and central nervous system products and respiratory drugs and vaccines. Its Diagnostic Products segment includes core laboratory systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion medicine; molecular diagnostics polymerase chain reaction (PCR) instrument systems; point of care systems; rapid diagnostics lateral flow testing products, and informatics and automation solutions. Its Nutritional Products segment includes various forms of infant formula and follow-on formula, adult and other pediatric nutritional products and others.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyBuyNeutral
Technical IndicatorsStrong BuyStrong BuyStrong BuyStrong BuyStrong Sell
SummaryStrong BuyStrong BuyStrong BuyStrong BuySell
  • anyone watching
    0
    • Going to $120
      0
      • Going to $120
        0
        • Dropping to low 80s on a bad earnings then maybe rebound
          5
          • so much for that prediction
            0